Latest News

 Filter by Provider

The Federal Reserve just raised interest rates for the first time in more than three years.

A falling share price is attracting investors to Nike stock.

Retirees can probably bank on a bigger COLA next year.

Genuine Parts (NYSE:GPC) executives outlined leadership plans, operating priorities and separation preparations as the company moves toward creating standalone automotive and industrial businesses. Chairman and Chief Executive Officer Will Stengel said the leadership selections were designed around

Finding the Best Kids Salon near me can make grooming a much easier and more enjoyable experience for both parents and children. A good kids salon is not s

These stocks offer above-average yields and solid dividend growth.

Healthy aging once focused mainly on treating diseases after they appeared. Modern care takes a broader view. It considers physical function, metabolic hea

Until Anthropic goes public, investors won't have any great options to get exposure to the performance of its shares.

Current estimates point to a significant boost, but it's not set in stone.

Corporations along with folks often mail solutions, papers, tools, along with personalized items derived from one of spot to an alternative. While transpor

The puzzle pieces are falling into place for subpar stock market returns.

Ackman quickly deployed the capital raised in his new $5 billion fund.

TSMC owns more than two-thirds of the chip foundry market.

Dubai has become a prominent destination for people looking to purchase property, establish a home, or explore real estate investment opportunities. The ci

The September Effect can sink stocks, but likely not these three.

Investors are staring at a market triple-whammy.

Retaining some sort of fresh setting is significant with households, locations, professional medical establishments, educational institutions, eateries, in

Sanofi (NASDAQ:SNY) is prioritizing continued growth in Specialty Care while preparing for the loss of exclusivity of Dupixent in the early part of the next decade, according to Manuela Buxo, the company’s executive vice president and head of Specialty Care. Speaking at a Morgan Stanley fireside ch

Cho Thuê Máy Photocopy Màu Tiết Kiệm Chi Phí NhấtNhiều văn phòng bỏ ra 80-150 triệu đồng mua máy photocopy màu mới, rồi sau 18 tháng nhận ra nhu cầu in đã

Tech stocks could be a greater risk than some investors realize.

Dogs and cats take company, convenience, along with delight straight into each of our existence. No matter whether anyone talk about your own home which ha

A new well-designed bathing room can be over simply a well-designed place. It can be a crucial portion of everyday activities wherever convenience, persona

While many seniors are hoping for a large cost-of-living adjustment (COLA), they won't actually be getting a raise in the traditional sense.

The title is moving to his son. The $365 billion isn't.

Current lifetime typically is included with far more stuff in comparison with readily available living space. No matter if that you are going into a comple

Bloom Energy is seeing massive earnings growth, while Plug Power is working to clean up its finances.

The market might seem bloated, but these stocks still have a long runway for growth.

Pacific Biosciences of California (NASDAQ:PACB) is maintaining its existing strategy while sharpening execution around clinical genomics, cost controls and the rollout of products designed to improve sequencing economics, Chief Executive Officer Mark Van Oene said during a Morgan Stanley discussion.

Shipment has grown to be a crucial component of current small business, in particular seeing that on the net looking, overseas deal, in addition to direct-

MPLX LP didn't just team up with a pipeline rival; it also teamed up with two rivals in the upstream sector, too.

Centene (NYSE:CNC) reaffirmed its 2026 adjusted diluted earnings-per-share guidance of more than $4.80 at the Deutsche Bank Healthcare Summit, with Chief Executive Officer Sarah London saying the company’s performance through the first two months of the third quarter was in line with expectations.

Royal Bank Of Canada (NYSE:RY) Chief Financial Officer Katherine Gibson said the bank has made progress toward the strategic and financial objectives outlined at its Investor Day, citing growth across Canadian and global businesses, improved profitability and cost discipline. Speaking at a Barclays

Tesla has grown at a torrential rate in the past, but it has slowed down recently.

One designs chips; the other manufactures them, and their valuations tell starkly different stories about growth versus value.

Rockwell Automation (NYSE:ROK) executives said customer sentiment remains broadly positive despite inflation, tariffs and trade-policy uncertainty, with manufacturers continuing to prioritize productivity, modernization and automation investments. Speaking at Morgan Stanley’s 14th Annual Laguna Con

Troim purchased shares indirectly through Drew Trust at $4.38 each, signaling confidence in the offshore drilling company following a strong 43% one-year return.

Life insurers generally benefit from higher rates, but there are some negatives to consider.

The provider of a software development lifecycle platform reported a notable insider disposition after its stock price soared.

Turn Your Earpiece Time Into Actual CashMobile phones have evolved far beyond simple communication gimmick or tool for social sensitive scrolling. Today, s

Incyte (NASDAQ:INCY) executives outlined a strategy centered on expanding its non-JAKAFI business, advancing a broader late-stage pipeline and preparing for the loss of exclusivity for JAKAFI after 2029. Chief Executive Officer Bill Meury said the company’s pipeline has changed substantially over t

The $72,000 ending is the easy part. Collecting it involved an 83% loss and a 15-year wait just to get back to even.

Nvidia's 55.6% net margin dwarfs Applied Materials' 24.7%, but one trades at a steep valuation premium while the other faces customer concentration risk.

Alnylam Pharmaceuticals (NASDAQ:ALNY) outlined its strategy for advancing zilebesiran, an investigational RNA interference, or RNAi, therapy designed to provide sustained blood-pressure control with twice-yearly dosing for people with uncontrolled hypertension and elevated cardiovascular risk. Duri

The Federal Open Market Committee (FOMC) just raised interest rates for the first time in three years.

The language learning platform provider reported a notable insider sale as its stock plunged 47% over the past year.

After the sale, West still held $6.1 million in stock.

Oracle's AI spending spree needs power and cooling to match. Two industrial stocks are already cashing in on that demand.

IAMGold (TSX:IMG) stock looks way too cheap to ignore despite euphoric five-year gains in the books.

Brookfield Asset Management (NYSE:BAM) used its 2026 Investor Day to outline plans to double fee-bearing capital by 2031, supported by fundraising across flagship funds, complementary strategies, insurance capital and private wealth products. Management also emphasized the July acquisition of the re

These Canadian stocks offer strong growth potential, with a few pulling back from their highs and now presenting attractive entry points.